A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

FULL DISCLOSURE: This is sponsored content for Cardiol Therapeutics.

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley reveals the enrollment of their first patient in the pivotal Phase 3 MAVERIC trial for recurrent pericarditis. In this concise interview, Elsley discusses how their oral drug therapy aims to prevent new episodes of this debilitating heart condition, the impressive Phase 2 results showing significant pain reduction, and the potential timeline for market entry by mid-2026.

With trial sites at prestigious institutions like Mass General, Cleveland Clinic, and Mayo Clinic, and a market potential approaching $1 billion by 2028, investors won’t want to miss this significant development in cardiovascular medicine.


FULL DISCLOSURE: Cardiol Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cardiol Therapeutics. The author has been compensated to cover Cardiol Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Can Europe Get Off Of Russian Gas? – The Daily Dive

Joining us for the final episode of the Daily Dive this week is frequent guest...

Friday, March 25, 2022, 01:30:00 PM

Driven By Stem: Focusing On Untapped Cannabis Ecommerce & Delivery Markets – The Daily Dive

Joining us for our mid-week episode of the Daily Dive, is that of Adam Berk,...

Wednesday, May 5, 2021, 01:30:00 PM

Lobo Tiggre: Evaluating Resource Companies – The Daily Dive

Today on the Daily Dive, we see our host Cassandra Leah sit down with Lobo...

Thursday, February 4, 2021, 01:30:00 PM

Barse: Rate Hikes Are Here, Don’t Own Fixed Income Instruments – The Daily Dive

Today on the Daily Dive, we sit down with David Barse, a returning guest and...

Monday, January 24, 2022, 01:30:00 PM

Bank Of America Lowers Gold Price Target To $2000? – The Daily Dive feat John-Mark Staude

Returning to the Daily Dive today is that of John-Mark Staude of Riverside Resources (TSXV:...

Wednesday, December 16, 2020, 01:00:00 PM